Galletto Paula, Leoz Maria Liz, Castells Antoni, Balaguer Francesc
Servicio de Gastroenterología, Hospital Clínic, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), IDIBAPS, Universidad de Barcelona, Barcelona, España.
Gastroenterol Hepatol. 2013 Nov;36(9):580-6. doi: 10.1016/j.gastrohep.2012.12.005. Epub 2013 Mar 29.
Desmoid tumors are currently the main cause of morbidity and mortality in patients with familial adenomatous polyposis. More than 10% of these patients will develop these tumors during their lifetime and more than a third will suffer their consequences. The main risk factors for their development are female sex and abdominal surgery. The most frequent localization is intraabdominal. The therapeutic approach to these tumors has changed, and the surgical treatment of choice is currently the subject of debate. If a watch and wait approach is adopted, more than 50% of tumors will prove to be indolent. Therefore, the therapeutic strategy should be based on clinical presentation and should be decided by a multidisciplinary team working in a center with experience of these tumors. The present article proposes a prognostic classification to guide the therapeutic approach.
硬纤维瘤目前是家族性腺瘤性息肉病患者发病和死亡的主要原因。超过10%的此类患者在其一生中会发生这些肿瘤,超过三分之一的患者会受到其影响。其发生的主要危险因素是女性性别和腹部手术。最常见的部位是腹腔内。这些肿瘤的治疗方法已经改变,目前首选的手术治疗方法存在争议。如果采用观察等待的方法,超过50%的肿瘤将被证明是惰性的。因此,治疗策略应基于临床表现,应由在处理这些肿瘤方面有经验的中心的多学科团队来决定。本文提出一种预后分类方法以指导治疗方法。